Solicitation of Nominations for Appointment to the Genomic Medicine Program Advisory Committee, 35741-35742 [2015-15219]

Download as PDF tkelley on DSK3SPTVN1PROD with NOTICES Federal Register / Vol. 80, No. 119 / Monday, June 22, 2015 / Notices Under 12 CFR 1.3(h)(2), a national bank may request an OCC determination that it may invest in an entity that is exempt from registration under section 3(c)(1) of the Investment Company Act of 1940 1 if the portfolio of the entity consists exclusively of assets that a national bank may purchase and sell for its own account. The OCC uses the information contained in the request as a basis for ensuring that a bank’s investment is consistent with its investment authority under applicable law and does not pose unacceptable risk. Under 12 CFR 1.7(b), a national bank may request OCC approval to extend the five-year holding period for securities held in satisfaction of debts previously contracted (DPC) for up to an additional five years. The bank must provide a clearly convincing demonstration of why any additional holding period is needed. The OCC uses the information in the request to ensure, on a case-bycase basis, that the bank’s purpose in retaining the securities is not speculative and that the bank’s reasons for requesting the extension are adequate. The OCC also uses the information to evaluate the risks to the bank of extending the holding period, including potential effects on the bank’s safety and soundness. Type of Review: Extension of a currently approved collection. Affected Public: Businesses or other for-profit. Estimated Number of Respondents: 25. Estimated Total Annual Burden: 460 hours. Frequency of Response: On occasion. The OCC published a 60-day Federal Register notice concerning this collection on April 14, 2015, (80 FR 20076). No comments were received. Comments continue to be invited on: (a) Whether the collection of information is necessary for the proper performance of the functions of the OCC, including whether the information has practical utility; (b) The accuracy of the OCC’s estimate of the burden of the collection of information; (c) Ways to enhance the quality, utility, and clarity of the information to be collected; (d) Ways to minimize the burden of the collection on respondents, including through the use of automated collection techniques or other forms of information technology; and (e) Estimates of capital or start-up costs and costs of operation, 1 15 U.S.C. 80a–3(c)(1). VerDate Sep<11>2014 17:45 Jun 19, 2015 Jkt 235001 maintenance, and purchase of services to provide information. Dated: June 17, 2015. Mary H. Gottlieb, Regulatory Specialist, Legislative and Regulatory Activities Division. [FR Doc. 2015–15255 Filed 6–19–15; 8:45 am] BILLING CODE 4810–33–P DEPARTMENT OF VETERANS AFFAIRS Solicitation of Nominations for Appointment to the Genomic Medicine Program Advisory Committee Department of Veterans Affairs. Notice. AGENCY: ACTION: The Department of Veterans Affairs (VA), Veterans Health Administration (VHA), is seeking nominations of qualified candidates to be considered for appointment as a member of the Genomic Medicine Program Advisory Committee (hereinafter referred to as ‘‘the Committee’’). The Committee was established by the Secretary of the VA pursuant to the provisions of the Federal Advisory Committee Act, as amended, 5 U.S.C. Appendix 2, to advise the Secretary with respect to the development of a world-class genomic medicine program within the Department, including policies to collect and utilize both genetic and other medical information to promote optimal medical care and research that contribute to the knowledge of diseases prevalent in Veterans. The Committee will be guided by the goal of using genetic information to optimize clinical care of Veterans, and enhance the study and development of diagnostic tests and treatments for diseases of particular relevance to Veterans. Nominations of qualified candidates in the area of genomic medicine from healthcare, academia, and/or other government agencies are being sought to fill vacancies on the Committee. DATES: Nominations for membership on the Committee must be received no later than 5:00 p.m. EDT on July 15, 2015. ADDRESSES: All nominations should be mailed to Veterans Health Administration, Department of Veterans Affairs, 810 Vermont Ave. NW. (10P9B), Attention: Sumitra Muralidhar; Washington, DC 20420, or emailed to Sumitra.muralidhar@va.gov. FOR FURTHER INFORMATION CONTACT: Dr. Sumitra Muralidhar, Designated Federal Officer, Genomic Medicine Program Advisory Committee, or by email at Sumitra.muralidhar@va.gov. A copy of SUMMARY: PO 00000 Frm 00118 Fmt 4703 Sfmt 4703 35741 the Committee charter and list of the current membership can be obtained by contacting Dr. Muralidhar. SUPPLEMENTARY INFORMATION: The Genomic Medicine Program Advisory Committee was established by the Secretary of VA. VHA is requesting nominations for two vacancies on the Committee. The Committee will be composed of approximately 12 members. The members of the Committee are appointed by the Secretary and include, but are not limited to: • Members of the medical and scientific communities representing disciplines such as, but not limited to, medical genetics, genomic technologies, bioinformatics, computation, statistical genetics, and genomic policy. To the extent possible, the Secretary seeks members who have diverse professional and personal qualifications. We ask that nominations include information of this type so that VA can ensure a balanced Committee membership. Individuals appointed to the Committee by the Secretary shall be invited to serve a two- or three-year term. The Secretary may reappoint a member for an additional term of service. Committee members will receive travel expenses and a per diem allowance for any travel made in connection with duties as members of the Committee and within federal travel guidelines. Requirements for Nomination Submission: Nominations should be typed (one nomination per nominator). Nomination package should include: (1) A letter of nomination that clearly states the name and affiliation of the nominee, the basis for the nomination (i.e., specific attributes which qualify the nominee for service in this capacity), and a statement from the nominee indicating the willingness to serve as a member of the Committee; (2) the nominee’s contact information, including name, mailing address, telephone numbers, and email address; (3) the nominee’s curriculum vitae (if applicable); (4) a summary of the nominee’s experience and qualifications relative to the membership considerations described above; and (5) a statement confirming that he/she is not a federally-registered lobbyist. VA makes every effort to ensure that the membership of VA Federal advisory committees is fairly balanced in terms of points of view represented and the committee’s function. Appointments to this Committee shall be made without discrimination based on a person’s race, color, religion, sex, sexual orientation, E:\FR\FM\22JNN1.SGM 22JNN1 35742 Federal Register / Vol. 80, No. 119 / Monday, June 22, 2015 / Notices gender identity, national origin, age, disability, or genetic information. Nominations must state that the nominee appears to have no conflict of interest that would preclude membership. An ethics review is conducted for each selected nominee. Dated: June 17, 2015. Rebecca Schiller, Advisory Committee Management Officer. [FR Doc. 2015–15219 Filed 6–19–15; 8:45 am] BILLING CODE 8320–01–P DEPARTMENT OF VETERANS AFFAIRS MyVA Advisory Committee tkelley on DSK3SPTVN1PROD with NOTICES Amend: Notice of Meeting. The Department of Veterans Affairs (VA) gives notice under the Federal Advisory Committee Act, 5 U.S.C. App. 2., that the MyVA Advisory Committee (MVAC) will meet July 14 and 15, 2015 at the Department of Veterans Affairs, Washington DC VA Medical Center, 50 Irving Street NW., Freedom Auditorium, Washington, DC 20422. The purpose of the Committee is to advise the Secretary, through the VerDate Sep<11>2014 17:45 Jun 19, 2015 Jkt 235001 Executive Director, My VA Task Force Office regarding the My VA initiative and VA’s ability to rebuild trust with Veterans and other stakeholders, improve service delivery with a focus on Veteran outcomes, and set the course for longer-term excellence and reform of the VA. On July 14 from 8:00 a.m. to 2:00 p.m., the Committee will convene a closed session in order to protect patient privacy as the Committee tours the Washington DC VA Medical Center. 5 U.S.C. 552b(b)(6). In the afternoon from 2:00 p.m. to 5:15 p.m., the Committee will reconvene in an open session to discuss the progress on and the integration of the work in the five key MyVA work streams—Veteran Experience (explaining the efforts conducted to improve the Veteran’s experience), Employees Experience, Support Services Excellence (such as information technology and human resources), Performance Improvement (projects undertaken to date and those upcoming), and VA Strategic Partnerships. On July 15, from 8:15 a.m. to 2:00 p.m., the Committee will discuss and PO 00000 Frm 00119 Fmt 4703 Sfmt 9990 recommend areas for improvement on VA’s work to date, plans for the future, and integration of the MyVA efforts. This session is open to the public. No time will be allocated at this meeting for receiving oral presentations from the public. However, the public may submit written statements for the Committee’s review to Debra Walker, Designated Federal Officer, MyVA Program Management Office, Department of Veterans Affairs, 1800 G Street NW., Room 880–40, Washington, DC 20420, or email at Debra.Walker3@va.gov. Any member of the public wishing to attend the meeting or seeking additional information should contact Ms. Walker. Because the meeting will be held in a Government building, anyone attending must be prepared to show a valid government issued photo ID. Please allow 15 minutes before the meeting begins for this process. Dated: June 17, 2015. Jelessa Burney, Federal Advisory Committee Management Officer. [FR Doc. 2015–15218 Filed 6–19–15; 8:45 am] BILLING CODE P E:\FR\FM\22JNN1.SGM 22JNN1

Agencies

[Federal Register Volume 80, Number 119 (Monday, June 22, 2015)]
[Notices]
[Pages 35741-35742]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-15219]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF VETERANS AFFAIRS


Solicitation of Nominations for Appointment to the Genomic 
Medicine Program Advisory Committee

AGENCY: Department of Veterans Affairs.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Department of Veterans Affairs (VA), Veterans Health 
Administration (VHA), is seeking nominations of qualified candidates to 
be considered for appointment as a member of the Genomic Medicine 
Program Advisory Committee (hereinafter referred to as ``the 
Committee''). The Committee was established by the Secretary of the VA 
pursuant to the provisions of the Federal Advisory Committee Act, as 
amended, 5 U.S.C. Appendix 2, to advise the Secretary with respect to 
the development of a world-class genomic medicine program within the 
Department, including policies to collect and utilize both genetic and 
other medical information to promote optimal medical care and research 
that contribute to the knowledge of diseases prevalent in Veterans. The 
Committee will be guided by the goal of using genetic information to 
optimize clinical care of Veterans, and enhance the study and 
development of diagnostic tests and treatments for diseases of 
particular relevance to Veterans. Nominations of qualified candidates 
in the area of genomic medicine from healthcare, academia, and/or other 
government agencies are being sought to fill vacancies on the 
Committee.

DATES: Nominations for membership on the Committee must be received no 
later than 5:00 p.m. EDT on July 15, 2015.

ADDRESSES: All nominations should be mailed to Veterans Health 
Administration, Department of Veterans Affairs, 810 Vermont Ave. NW. 
(10P9B), Attention: Sumitra Muralidhar; Washington, DC 20420, or 
emailed to Sumitra.muralidhar@va.gov.

FOR FURTHER INFORMATION CONTACT: Dr. Sumitra Muralidhar, Designated 
Federal Officer, Genomic Medicine Program Advisory Committee, or by 
email at Sumitra.muralidhar@va.gov. A copy of the Committee charter and 
list of the current membership can be obtained by contacting Dr. 
Muralidhar.

SUPPLEMENTARY INFORMATION: The Genomic Medicine Program Advisory 
Committee was established by the Secretary of VA.
    VHA is requesting nominations for two vacancies on the Committee. 
The Committee will be composed of approximately 12 members. The members 
of the Committee are appointed by the Secretary and include, but are 
not limited to:
     Members of the medical and scientific communities 
representing disciplines such as, but not limited to, medical genetics, 
genomic technologies, bioinformatics, computation, statistical 
genetics, and genomic policy.
    To the extent possible, the Secretary seeks members who have 
diverse professional and personal qualifications. We ask that 
nominations include information of this type so that VA can ensure a 
balanced Committee membership.
    Individuals appointed to the Committee by the Secretary shall be 
invited to serve a two- or three-year term. The Secretary may reappoint 
a member for an additional term of service. Committee members will 
receive travel expenses and a per diem allowance for any travel made in 
connection with duties as members of the Committee and within federal 
travel guidelines.
    Requirements for Nomination Submission: Nominations should be typed 
(one nomination per nominator). Nomination package should include: (1) 
A letter of nomination that clearly states the name and affiliation of 
the nominee, the basis for the nomination (i.e., specific attributes 
which qualify the nominee for service in this capacity), and a 
statement from the nominee indicating the willingness to serve as a 
member of the Committee; (2) the nominee's contact information, 
including name, mailing address, telephone numbers, and email address; 
(3) the nominee's curriculum vitae (if applicable); (4) a summary of 
the nominee's experience and qualifications relative to the membership 
considerations described above; and (5) a statement confirming that he/
she is not a federally-registered lobbyist.
    VA makes every effort to ensure that the membership of VA Federal 
advisory committees is fairly balanced in terms of points of view 
represented and the committee's function. Appointments to this 
Committee shall be made without discrimination based on a person's 
race, color, religion, sex, sexual orientation,

[[Page 35742]]

gender identity, national origin, age, disability, or genetic 
information. Nominations must state that the nominee appears to have no 
conflict of interest that would preclude membership. An ethics review 
is conducted for each selected nominee.

    Dated: June 17, 2015.
Rebecca Schiller,
Advisory Committee Management Officer.
[FR Doc. 2015-15219 Filed 6-19-15; 8:45 am]
BILLING CODE 8320-01-P